> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Guide on ANDA Post-Complete Response Letter Meetings
- URL: https://www.fdaweb.com/guide-on-anda-post-complete-response-letter-meetings/
- Published: 2018-12-04T12:00:00.000Z
- Updated: 2026-09-15T00:48:22.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5142958

*Federal Register* notice: FDA has made available a final guidance entitled “Post-Complete Response Letter Meetings Between FDA and ANDA Applicants Under GDUFA.” The document provides procedures that will promote well-managed post-CRL meetings and help ensure that such meetings are scheduled and conducted in accordance with the commitments made by FDA in connection with the reauthorization of the Generic Drug User Fee Amendments for Fiscal Years 2018–2022\. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-12-04/pdf/2018-26285.pdf?ref=fdaweb.com).